Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,311,046
+$250,898 QoQ
Shares Held
33,549
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,111
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $71,666,047 across 14 Drug Manufacturers - General names. MRK ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
51,320 | $18,583,998 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
110,868 | $14,007,063 | |
| 3 | LLY |
ELI LILLY & Co
|
9,538 | $11,440,164 | |
| 4 | JNJ |
Johnson & Johnson
|
32,688 | $8,301,771 | |
| 5 | ABBV |
AbbVie Inc.
|
26,168 | $6,584,915 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
33,549 | $4,311,046 | |
| 7 | BIIB |
Biogen Inc.
|
8,560 | $1,849,473 | |
| 8 | PFE |
Pfizer Inc
|
73,381 | $1,767,014 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,311,046 | 33,549 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,060,148 | 33,753 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,946,062 | 46,989 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,340,665 | 39,803 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,215,637 | 40,622 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,855,730 | 42,956 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,369,460 | 43,923 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,526,851 | 48,669 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,831,475 | 47,104 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,460,535 | 48,962 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,583,023 | 51,211 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,053,300 | 49,085 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,780,115 | 50,092 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,224,280 | 49,105 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,682,082 | 51,213 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $4,446,547 | 51,632 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,068,596 | 55,595 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,059,285 | 61,661 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,229,913 | 68,240 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,071,502 | 67,521 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,218,289 | 67,099 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,164,184 | 66,989 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,671,518 | 69,334 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $8,243,989 | 99,385 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,814,154 | 113,981 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $6,824,190 | 88,695 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||